http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2386740-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2007-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cf6e62b628c997f56f2d5baa0989014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b89f581a0220bc9eef01c8dd18a530d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b08aa509dadaeeda921685eec676df7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_117606db630f6d7154ba08b8c8452471 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0d1cbda228866d7d7cca1ba7987bfa9 |
| publicationDate | 2012-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2386740-T3 |
| titleOfInvention | PIPERAZIN-ENAMINAS as antiviral agents |
| abstract | A compound of Formula 1, or a pharmaceutically acceptable salt thereof, in which: A is selected from the group consisting of: ** Formula ** R1 is hydrogen or C1-C4 alkyl; R2 is hydrogen; R4 is selected from the group consisting of hydrogen, halogen, hydroxyl and O (C1-C4 alkyl); R5 10 is hydrogen, halogen, or (C1-C4 alkyl); R6 is selected from the group consisting of hydrogen, halogen or (C1-C4 alkyl) ; R7 is independently selected from the group consisting of hydrogen, halogen and B; R4N does not exist; in which - represents a carbon-carbon bond or does not exist; U and V are independently selected from hydrogen, cyano, COOH, phenyl or pyridyl with the proviso that at least one must be cyano or COOH; Z is selected from the group consisting of CF3, C4-C7 alkyl, phenyl, C4-C7 cycloalkyl, C4-C7 cycloalkenyl, pyridinyl, C2-C5 alkoxy, a heteroaryl 5-membered monocyclic containing 1 to 2 nitrogens, an N linked yet heteroalicyclic 6-member ico containing 1 or 2 nitrogen, a C4-C6 lactam bound by lalactam nitrogen or a cyano, in which said aryl or heteroaryl or lactam are independently optionally substituted with one to two groups selected from halogen or C1- alkyl C3; B is selected from the group consisting of chloro, methoxy, tetrazolyl, -triazolyl, pyrazolyl, imidazolyl, pyrrolyl, pyrazinyl and XR8a, in which these are optionally substituted with one to three odifferent equal halogens or one to three equal substituents or different selected from group F; F is selected from the group consisting of (C1-3) alkyl, heteroalicyclic, hydroxymethyl, halogen, -COOH, -COO-(C1-3) alkyl, amino, -NHCH3, -N (CH3 )2, |
| priorityDate | 2006-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 442.